DAVID BRISTER: Open Payments
NPI 1568409589 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 33 payments from 10 companies in 2025. Trend: 2023 $1,790 · 2024 $1,325 · 2025 $1,289
Food & beverage: $1,289
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $319 |
| AstraZeneca Pharmaceuticals LP | 8 | $278 |
| Lilly USA, LLC | 6 | $189 |
| Phathom Pharmaceuticals, Inc. | 2 | $144 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Eisai Inc. | 3 | $88 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: BREZTRI, Ozempic, VOQUEZNA, KISUNLA, REXULTI, Wegovy, AIRSUPRA, Leqembi.
Industry payments across TX — which companies pay providers there.
